Enhancement of in vitro antitumour activity of epirubicin in HER2+ breast cancer cells using immunoliposome formulation

Enhancement of in vitro antitumour activity of epirubicin in HER2+ breast cancer cells using immunoliposome formulation

Abstract Epirubicin (EPI) is one of the potent breast cancer (BC) chemotherapeutic agents, but its adverse effects limit its efficacy. Herein, EPI was selected to be loaded in liposomal carrier, which has been targeted by a monoclonal antibody, Herceptin. The preparation process of liposomes was a m...

Full description

Saved in:
Bibliographic Details
Main Authors: Farnaz Khaleseh, Abbas Hemmati Azandaryani, Fatemeh Fathian Kolahkaj, Mozafar Khazaei, Katayoun Derakhshandeh
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:IET Nanobiotechnology
Subjects:
biomedical materials
cancer
cellular biophysics
drug delivery systems
drugs
encapsulation
Online Access:https://doi.org/10.1049/nbt2.12012
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1049/nbt2.12012

Similar Items